Edwards Lifesciences Corp (EW.N)

EW.N on New York Stock Exchange

133.02USD
27 Feb 2015
Change (% chg)

$-1.88 (-1.39%)
Prev Close
$134.90
Open
$134.40
Day's High
$135.16
Day's Low
$133.02
Volume
678,130
Avg. Vol
213,654
52-wk High
$137.54
52-wk Low
$66.86

EW.N

Chart for EW.N

About

Edwards Lifesciences Corporation (Edwards Lifesciences) is focused on technologies that treat structural heart disease and critically ill patients. A pioneer in the development and commercialization of heart valve products, Edwards Lifesciences is the manufacturer of tissue heart valves and repair products used to replace or... (more)

Overall

Beta: 0.65
Market Cap(Mil.): $14,344.87
Shares Outstanding(Mil.): 107.84
Dividend: --
Yield (%): --

Financials

Search Stocks

UPDATE 1-Edwards raises 2015 earnings forecast; sees bigger forex hit

Feb 3 - Edwards Lifesciences Corp on Tuesday raised its 2015 earnings forecast to reflect strong demand for its non-invasive heart valve replacement system, but revised its overall sales forecast to account for a larger negative impact of foreign exchange due to the strong dollar .

04 Feb 2015

Edwards raises 2015 earnings forecast; sees bigger forex hit

Feb 3 - Edwards Lifesciences Corp on Tuesday raised its 2015 earnings forecast to reflect strong demand for its non-invasive heart valve replacement system, but revised its overall sales forecast to account for a larger negative impact of foreign exchange due to the strong dollar .

04 Feb 2015

Edwards CEO hopes FDA to accelerate approvals of medical devices

NEW YORK - U.S. health regulators appear open to speeding up approvals of medical devices that currently often reach European markets three to five years ahead of being cleared in the United States, the chief executive officer of Edwards Lifesciences said.

09 Dec 2014

UPDATE 1-Edwards Lifesciences Q3 net rises 23 pct, outlook increased

Oct 23 - Medical device maker Edwards Lifesciences Corp on Thursday said its quarterly net earnings rose 23 percent on strong sales of heart valves, prompting the company to raise its full-year earnings outlook and sending its shares up 7 percent.

24 Oct 2014

Edwards 3rd quarter net rises 23 pct, 2014 outlook increased

Oct 23 - Medical device maker Edwards Lifesciences Corp on Thursday said its quarterly net earnings rose 23 percent due to strong sales of heart valves, prompting the company to raise its full-year earnings outlook.

24 Oct 2014

Allergan CEO resigns from Edwards Lifesciences' board

Oct 3 - Edwards Lifesciences Corp said David Pyott resigned from the medical device maker's board to devote more time to his role as chairman and CEO of Allergan Inc .

04 Oct 2014

Earnings vs. Estimates

Search Stocks